The adoption of critical process parameters and specifications is crucial during: Response:

Question

Options

• AThe conceptual design phase
• BPhase II clinical trials
• CMarketing campaign development
• DAll phases of development

• A
  8% (3)
• B
  3% (1)
• C
  11% (4)
• D
  78% (28)

Explanation

Option D is correct because critical process parameters (CPPs) and specifications must be identified, monitored, and refined throughout all phases of development - from early research through commercial manufacturing - as product understanding deepens over time. The conceptual design phase (A) is too early and narrow; while initial targets may be set, CPPs cannot be fully "adopted" without the process knowledge gained in later stages. Phase II clinical trials (B) represent only a mid-development milestone, and locking specifications solely at that point would ignore critical data generated in Phase III and scale-up activities. Marketing campaign development (C) is a commercial activity completely outside the technical/scientific domain of process parameter management.

Memory tip: Think of CPPs like a living document - they evolve and get refined at every checkpoint from lab bench to commercial batch, so no single phase owns them. "All phases = always critical" is the key phrase to anchor this concept.

No community discussion yet for this question.